Hjem › Myelofibrose › Utah
Myelofibrose kliniske forsøg i Utah
10 studier for Myelofibrose søger deltagere på steder i Utah.
Byer i Utah
Officiel studietekst (engelsk)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04176198Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
- Huntsman Cancer Institute at University of Utah, Salt Lake City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07521046A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06661915A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute At University of Utah, Salt Lake City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT07441694AlloHCT With PegINFa for Myelofibrosis
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT05535764Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- University of Utah, Salt Lake City
RekruttererFase 1
Alder 13 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT04771572A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Huntsman Cancer Institute, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 12. feb. 2026 · NCT05980806SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- University of Utah, Huntsman Cancer Institute, Salt Lake City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2025 · NCT06479135Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.